Ohio Depo-Provera Lawsuit Lawyers

Tireless Advocacy for Those Who Developed Brain Tumors from Depo-Provera Use

Depo-Provera is a popular contraceptive option, primarily used by women seeking a long-term solution to prevent pregnancy without the need for daily pills. Administered through an injection every three months, Depo-Provera relies on the synthetic hormone medroxyprogesterone acetate (a form of progestin) to effectively prevent pregnancy. 

While Depo-Provera has been marketed as a convenient and effective birth control option, growing evidence has raised serious questions about its long-term safety. Specifically, a recent study suggests that prolonged use of medroxyprogesterone acetate may increase the risk of developing meningioma, a type of brain tumor that can carry life-altering consequences.

The severity of a meningioma diagnosis varies by case. Still, the potential for surgery, therapy, and ongoing medical care can place immense physical, emotional, and financial strain on patients and their families. As such, individuals impacted by Depo-Provera-related meningioma deserve the opportunity to seek accountability from the manufacturer, Pfizer, for the harm caused by the drug.

Hilliard Law can help Ohio residents explore their legal options. Backed by over 100 years of combined experience in dangerous drug cases, our firm stands by clients from the initial consultation through every stage of their case. If you or a loved one developed a brain tumor after using Depo-Provera, we may be able to assist in pursuing compensation for tangible and intangible losses, such as medical bills, lost wages, and pain and suffering.

If you have questions about your rights or the process of filing a claim, contact us at (361) 882-1612 or reach out online to schedule a consultation.

Examining the Possible Connection Between Depo-Provera Use and Meningioma Brain Tumors

A meningioma is a type of tumor that forms on the membranes surrounding the brain and spinal cord, known as the meninges. While most meningiomas are benign, meaning they don’t typically spread to other parts of the body, they can still pose serious health risks. These tumors can press against critical brain structures, potentially impeding nerve function and causing debilitating symptoms. In some cases, untreated meningiomas can become life-threatening, making surgical removal necessary. 

Common symptoms often include:

• Persistent headaches
• Changes in vision
• Memory difficulties 

These symptoms can significantly impact an individual’s quality of life.

Scientific Evidence Linking Depo-Provera to Meningioma Risk

A recent study published in The BMJ in March 2024 has brought to light findings regarding Depo-Provera and its potential to increase the risk of meningioma. Conducted in France, this large-scale study analyzed the medical records of over 108,000 women. 

Findings showed that women who used medroxyprogesterone acetate, especially those on it for over 12 months, were at a significantly higher risk—up to five times more likely—of developing a meningioma compared to those who did not use the contraceptive.

Why Hormones in Depo-Provera May Increase Tumor Risk

Depo-Provera relies on a synthetic hormone, medroxyprogesterone acetate, a progestin that mimics the effects of natural progesterone. Many meningiomas contain hormone receptors, including those for progesterone. Prolonged exposure to high levels of progestin can overstimulate these receptors, potentially accelerating tumor growth. 

Research suggests that the longer a person is exposed to Depo-Provera’s high progestin levels, the greater the risk of meningioma development, especially among those receiving multiple doses.

Determining Eligibility for a Depo-Provera Lawsuit

To seek legal recourse, individuals must meet specific criteria that demonstrate a link between Depo-Provera use and a meningioma diagnosis. 

While each case is unique, the following general qualifications are used to determine eligibility:

• Depo-Provera use for more than one year: Women who have used Depo-Provera as birth control for at least one continuous year, equating to four or more injections, may qualify.
• Diagnosis of meningioma: Eligibility also requires a confirmed diagnosis of meningioma. The diagnosis should reflect that the tumor developed after or during the period of Depo-Provera use, aligning with the research showing a connection between prolonged progestin exposure and the risk of meningioma.

Legal Rights and Options for Those Affected by Depo-Provera Use

Individuals harmed by a dangerous or defective drug have the right to seek compensation through legal action. For those who have used Depo-Provera and developed a meningioma brain tumor, this means pursuing justice for the harm caused by a drug they believed to be safe. 

At the heart of a Depo-Provera lawsuit is the claim that the manufacturer, Pfizer, failed to adequately warn consumers of the potential risks associated with prolonged use of the drug. Additionally, the lawsuit may argue that Depo-Provera’s design is inherently flawed, as the high dose of progestin it delivers poses serious health risks that outweigh its benefits, rendering it unreasonably unsafe for consumers.

Those who meet the eligibility criteria and proceed with a Depo-Provera lawsuit may be entitled to various forms of compensation to help address the physical, emotional, and financial toll of their diagnosis. 

Potential compensation types include:

• Medical expenses: Coverage for past and anticipated future medical costs related to diagnosing and treating meningioma, including surgeries, therapies, and follow-up care.
• Lost income: Compensation for wages lost due to medical treatments, inability to work, and potential future earnings if the injury affects long-term employment opportunities.
• Pain and suffering: Damages that address the ongoing physical pain, mental anguish, and emotional suffering caused by the tumor and its treatment.
• Loss of enjoyment of life: Compensation for how meningioma may diminish an individual’s ability to engage in activities and experience life as they once did.
• Shortened life expectancy: For those whose diagnosis has impacted their projected lifespan, additional compensation may be available to reflect this profound loss.

Choose Our Team for Your Depo-Provera Brain Tumor Case

Hilliard Law brings years of experience handling dangerous drug cases, equipping us to take on challenging lawsuits involving pharmaceutical giants. Our legal team recognizes the intricacies of these cases and has a track record of advocating for individuals harmed by unsafe medications. When dealing with a life-altering diagnosis, like a brain tumor potentially linked to Depo-Provera, you need legal representation from an attorney dedicated to pursuing a favorable outcome.

If you or someone you know has developed a brain tumor potentially linked to Depo-Provera use, contact us at (361) 882-1612 to discuss your case with one of our lawyers. We provide representation in Ohio.